About InSilixa
InSilixa is a company based in Sunnyvale (United States) founded in 2012 by Arjang Hassibi. It operates as a B2B. InSilixa has raised $13 million across 2 funding rounds from investors including HHS, PointGuard Ventures and Morningside. The company has 40 employees as of December 31, 2022. InSilixa operates in a competitive market with competitors including Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others.
- Headquarter Sunnyvale, United States
- Employees 40 as on 31 Dec, 2022
- Founders Arjang Hassibi
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Insilixa, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13 M (USD)
in 2 rounds
-
Latest Funding Round
$13 M (USD), Series A
Oct 22, 2014
-
Investors
HHS
& 2 more
-
Employee Count
40
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of InSilixa
InSilixa has successfully raised a total of $13M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $13 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $13.0M
-
First Round
First Round
(09 Sep 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2014 | Amount | Series A - InSilixa | Valuation | PointGuard Ventures , Morningside |
|
| Sep, 2013 | Amount | Grant - InSilixa | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InSilixa
InSilixa has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, PointGuard Ventures and Morningside. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology investments are made by PointGuard Ventures.
|
Founded Year | Domain | Location | |
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InSilixa
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InSilixa
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Insilixa Comparisons
Competitors of InSilixa
InSilixa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Food safety technologies are provided for pathogen identification.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about InSilixa
When was InSilixa founded?
InSilixa was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is InSilixa located?
InSilixa is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Who is the current CEO of InSilixa?
Arjang Hassibi is the current CEO of InSilixa. They have also founded this company.
Is InSilixa a funded company?
InSilixa is a funded company, having raised a total of $13M across 2 funding rounds to date. The company's 1st funding round was a Grant of $1.79M, raised on Sep 09, 2013.
How many employees does InSilixa have?
As of Dec 31, 2022, the latest employee count at InSilixa is 40.
What does InSilixa do?
InSilixa, founded in 2012 in Sunnyvale, United States, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and point-of-care. Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Who are the top competitors of InSilixa?
InSilixa's top competitors include Cepheid, Prenetics and Clear Labs.
Who are InSilixa's investors?
InSilixa has 3 investors. Key investors include HHS, PointGuard Ventures, and Morningside.